Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: Randomised controlled trial

British Journal of Psychiatry

Volumn 188, Issue APR., 2006, Pages 337-345

  Kendrick, Tony ^a   Peveler, Robert ^a   Longworth, Louise ^b   Baldwin, David ^a   Moore, Michael ^c   Chatwin, Judy ^a   Thornett, Andrew ^d   Goddard, Jonathan ^a   Campbell, Michael ^e   Smith, Helen ^f   Buxton, Martin ^b   Thompson, Christopher ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c Three Swans Surgery   (United Kingdom)

^d STAFFORDSHIRE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DOSULEPIN; FLUOXETINE; IMIPRAMINE; LOFEPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEPRESSION; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

EID: 33645656599     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.188.4.337     Document Type: Article

References (27)

1. British Medical Association & Royal Pharmaceutical Society of Great Britain (2001) British National Formulary (September issue). London & Wallingford: BMJ Books & Pharmaceutical Press.
2. Brown, J. S., Smith, R. R., Cantor, T., et al (1997) General practitioners as providers of minor surgery - a success story? British Journal of General Practice, 47, 205-210.
3. Canadian Coordinating Office for Health Technology Assessment (1997) A Clinical and Economic Evaluation of Selective Serotonin Reuptake Inhibitors in Major Depression. Ottawa: CCOHTA.
4. Dolan, P. (1997) Modelling valuations for Euroqol health states. Medical Care. 35, 1095-1108.
5. Doyle, J. J., Casciano, J., Arikian, S., et al (2001) A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs. Value Health, 4, 16-31.
6. Drug and Therapeutics Bulletin (2003) Mild depression in general practice: time for a rethink? Drug and Therapeutics bulletin, 41, 64.
7. Einarson, T. R., Arikian, S., Sweeney, S., et al (1995) A model to evaluate the cost-effectiveness of oral therapies in the management of patients with major depressive disorders. Clinical Therapeutics, 17, 136-153.
8. EuroQol Group (1990) EQ-5D: a new facility for the measurement of health related quality of life. Health Policy, 16, 199-208.
9. Forder, J., Kavanagh, S. & Fenyo, A. (1996) A comparison of the cost effectiveness of sertraline versus tricyclic antidepressants in primary care. Journal of Affective Disorders, 38, 97-111.
10. Hatziandreu, E. J., Brown, R. E., Revicki, D. A., et al (1994) Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin. Pharmacoeconomics, 5, 249-264.
11. Hosak, L., Tuma, I., Hanus, H., et al (2000) Costs and outcomes of use of amitriptyline, citalopram and fluoxetine in major depression: exploratory study. Acta Medico, 43, 133-136.
12. Jonsson, B. & Bebbington, P. E. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry, 164, 665-673.
13. Kendrick, T., Stevens, L., Bryant, A., et al (2001) Hampshire Depression Project: changes in the process of care and cost consequences. British Journal of General Practice, 51, 911-913.
14. Lewis, G., Pelosi, A. J., Araya, R. C., et al (1992) Measuring psychiatric disorder in the community: the development of a standardised assessment for use by lay interviewers. Psychological Medicine, 22, 465-486.
15. Manly, B. F. J. (1997) Randomisation, Bootstrap and Monte Carlo Methods in Biology (2nd edn). London: Chapman & Hall.
16. Meltzer, H., Gill, B. & Petticrew, M. (1994) The Prevalence of Psychiatric Morbidity Among Adults Aged 16-64, Living in Private Households, in Great Britain. London: Office for Population Censuses and Surveys.
17. Moffett, J. K., Torgerson, D., Bell-Syer, S. B., et al (1999) Randomised controlled trial of exercise for low back pain: clinical outcomes, costs and preferences. BMJ, 319, 279-283.
18. National Collaborating Centre for Mental Health (2004) Depression, Management of Depression in Primary and Secondary Care. London: National Institute for Clinical Excellence.
19. National Institute for Clinical Excellence (2004) Guide to the Methods of Technology Appraisals. London: NICE.
20. Netten, A., Rees, T. & Harrison, G. (2001) Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit, University of Canterbury.
21. Ratcliffe, J., Ryan, M. & Tucker, J. (1996) The costs of alternative types of routine antenatal care for low-risk women: shared care vs care by general practitioners and community midwives. Journal of Health Services and Research Policy, 1, 135-140.
22. Simon, G. E., von Korff, M., Heiligenstein, M., et al (1996) Initial antidepressant choice in primary care - effectiveness and cost of fluoxetine vs tricyclic antidepressarrts. JAMA, 275, 1897-1902.
23. Stewart, A. (1994) Antidepressant pharmacotherapy: cost companson of SSRIs and TCAs. British Journal of Medical Economics. 7, 67-79.
24. Ware, J., Snow, K. K., Kosinski, M., et al (1993) SF-36 Health Survey, Manual and Interpretation Guide. Boston: Health Institute, New England Medical Center.
25. Woods, S. W. & Rizzo, J. A. (1997) Cost-effectiveness of antidepressant treatment reassessed. British Journal of Psychiatry, 170, 257-263.
26. World Health Organization (1992) International Statistical Classification of Diseases and Related Health Problems (ICD-10). Geneva: WHO.
27. Zigmond, A. S. & Snaith, R. P. (1983) The Hospital Anxiety and Depression Rating Scale. Acta Psychiatrica Scandinavica, 67, 361-370.